Kimia Biosciences Limited (BOM:530313)
30.01
-0.98 (-3.16%)
At close: Jan 23, 2026
Kimia Biosciences Revenue
Kimia Biosciences had revenue of 339.99M INR in the quarter ending September 30, 2025, with 20.66% growth. This brings the company's revenue in the last twelve months to 1.26B, up 17.66% year-over-year. In the fiscal year ending March 31, 2025, Kimia Biosciences had annual revenue of 1.19B with 13.39% growth.
Revenue (ttm)
1.26B
Revenue Growth
+17.66%
P/S Ratio
1.13
Revenue / Employee
5.04M
Employees
250
Market Cap
1.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.19B | 140.44M | 13.39% |
| Mar 31, 2024 | 1.05B | -236.40M | -18.39% |
| Mar 31, 2023 | 1.29B | 36.15M | 2.89% |
| Mar 31, 2022 | 1.25B | -78.13M | -5.89% |
| Mar 31, 2021 | 1.33B | 264.28M | 24.86% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.28B |
| Infinium Pharmachem | 1.57B |
| Influx Healthtech | 1.24B |
| Smruthi Organics | 1.20B |
| Panchsheel Organics | 1.03B |
| Resonance Specialties | 852.48M |
| Tyche Industries | 570.25M |
| Vasundhara Rasayans | 329.60M |